Concepedia

Charles Wakeford

CW

6

Publications

578

Citations

6

H-Index

2003

Active since

Affiliations

Gilead Sciences (Australia)(Current)

University of the Witwatersrand

Gilead Sciences (United States)

Charles Wakeford is an author at Gilead Sciences (Australia) specializing in pharmacokinetic modeling, medicine, and pre-clinical pharmacology.

Top concepts

Publications per year

2003–2017

6

Publications

6

Severe Hepatotoxicity Associated with Nevirapine Use in HIV‐Infected Subjects

Ian Sanne, Herve Momméja-Marin, John E. Hinkle et al. · The Journal of Infectious Diseases · 2005 · 242 citations · Full text

Pharmacokinetic and Pharmacodynamic Characteristics of Emtricitabine Support Its Once Daily Dosing for the Treatment of HIV Infection

Laurene H. Wang, John Begley, R. L. St. Claire et al. · AIDS Research and Human Retroviruses · 2004 · 125 citations

Pharmacokinetic and Pharmacodynamic Characteristics of Emtricitabine Support Its Once Daily Dosing for the Treatment of HIV Infection

Laurene H. Wang, John Begley, Robert L. St. Claire et al. · AIDS Research and Human Retroviruses · 2004 · 109 citations

, , +21

Prospective Randomized Trial of Emtricitabine versus Lamivudine Short‐Term Monotherapy in Human Immunodeficiency Virus–Infected Patients

Franck Rousseau, Charles Wakeford, Herve Momméja-Marin et al. · The Journal of Infectious Diseases · 2003 · 65 citations · Full text

Mutations in the thumb–connection and RNase H domain of HIV type-1 reverse transcriptase of antiretroviral treatment-experienced patients

Joshua M Waters, Wesley T. O’Neal, Kirsten White et al. · Antiviral Therapy · 2009 · 26 citations · Full text

Rows per page

1–5 of 6